S Fahn, D B Calne. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Amantadine/therapeutic useCarboxy-Lyases/antagonists & inhibitorsLevodopa/adverse effectsLevodopa/therapeutic useParasympatholytics/therapeutic useParkinson Disease/drug therapy
Substances: See more » ParasympatholyticsLevodopaAmantadineCarboxy-Lyases
Year: 1978 PMID: 339124 DOI: 10.1212/wnl.28.1.5
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910